Analysts forecast lumpectomy market in the US to grow at a CAGR of 4.61% during the period 2018-2022. One trend in the market is presence of venture capitalists.
Most of the companies that are focusing on developing lumpectomy products are US-based companies.
Access Sample Report at www.reportsnreports.com/contacts/r…aspx?name=1333190.
They are focused on developing novel technologies and to bring those products into the market for which they need funding for R&D and to conduct clinical trials. Hence, both small and large companies, which manufacture lumpectomy products, need funding sources or investors.
Major key players in the lumpectomy market in the US: Carl Zeiss Meditec, Cianna Medical, DUNE Medical Devices, Endomagnetics, Focal Therapeutics, and iCAD.
According to the lumpectomy market report, one driver in the market is growing incidence of new breast cancer cases. According to various sources, the number of new breast cancer cases has increased by 4-5 folds in the US from 1980 to 2017.
According to various studies, obesity and hormone replacement therapies are the key factors that increased the number of breast cancer cases. According to the NCI in 2014, around 89.7% women survived breast cancer during 2007-2013.
Further, the lumpectomy market report states that one challenge in the market is high cost of lumpectomy procedure. The high cost of lumpectomy procedure is negatively affecting the adoption of lumpectomy products.
In the below-mentioned table, some of the cost components are mentioned, which can increase the financial burden on patients.
Key questions answered in this report
What will the market size be in 2022 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
Access report at www.reportsnreports.com/purchase.aspx?name=1333190.
Few Points from List of Exhibits:
Exhibit 1: Lumpectomy procedure
Exhibit 2: Parent market
Exhibit 3: Segmentation of global medical devices market 2017
Exhibit 4: Market characteristics
Exhibit 5: Market segments
Exhibit 6: Market definition - Inclusions and exclusions checklist
Exhibit 7: Market impact analysis: Government plans and ACTs for breast cancer
Exhibit 8: Percentage of new breast cancer cases by age group 2010-2014
Exhibit 9: Market impact analysis of clinical research
Exhibit 10: Market size 2017
Exhibit 11: Validation techniques employed for market sizing 2017
Exhibit 12: Lumpectomy market in US Market size and forecast 2017-2022 ($ bn)
Exhibit 13: Lumpectomy market in US Year-over-year growth 2018-2022 (%)
Exhibit 14: Five forces analysis 2017
Exhibit 15: Five forces analysis 2022
Exhibit 16: Bargaining power of buyers
Exhibit 17: Bargaining power of suppliers
Exhibit 18: Threat of new entrants
Exhibit 19: Threat of substitutes
Exhibit 20: Threat of rivalry